Edwin Kim, MD: Round One
In the first part of a discussion on treatment modalities in food allergy, R. Sharon Chinthrajah, MD, and Edwin H. Kim, MD, take a deep dive into the results of the OUtMATCH study and the recent FDA approval of omalizumab.
Moderator Sharon Chinthrajah, MD, conducts a series of investigative interviews with a fellow healthcare professional, exploring each aspect of food allergies from a new lens. A new topic will publish each month.
â–¶ 11 mins
â–¶ 10 mins
â–¶ 3 mins
